一例新型冠状病毒肺炎(危重型)患者的救治:遏制炎症风暴,转危为安( 三 )


参考文献:
[1].BellaniG,LaffeyJG,PhamT,etal.Epidemiology,patternsofcare,andmortalityforpatientswithacuterespiratorydistresssyndromeinintensivecareunitsin50countries[J].JAMA.2016,315(8):788-800.
[2].Fran?oisArrivé,RémiCoudroy,ArnaudWThille.EarlyIdentificationandDiagnosticApproachinAcuteRespiratoryDistressSyndrome(ARDS)[J].Diagnostics(Basel).2021Dec8;11(12):2307.
[3].JesúsVillar,CarlosFerrando,DomingoMartínez,etc.Dexamethasonetreatmentfortheacuterespiratorydistresssyndrome:amulticentre,randomisedcontrolledtrial[J].LancetRespirMed.2020Mar;8(3):267-276.
[4].KennethPSteinberg,LeonardDHudson,etc.Efficacyandsafetyofcorticosteroidsforpersistentacuterespiratorydistresssyndrome[J].NEnglJMed.2006Apr20;354(16):1671-84.
[5].WangD,etal.ClinicalCharacteristicsof138HospitalizedPatientsWith2019NovelCoronavirusinfectedPneumoniainWuhan,China[J].JAMATheJournaloftheAmericanMedicalAssociation,2020.
[6].杨志伟,贾红炜,等.在新型冠状病毒肺炎致急性呼吸窘迫综合征中的作用[J].河北医科大学学报,2022,10,43(10):1224-1228.
[7].XiaoxinGao,etal.Efficacy,safety,andpharmacoeconomicsofsivelestatsodiuminthetreatmentofsepticacuterespiratorydistresssyndrome:aretrospectivecohortstudy[J].AnnPalliatMed2021;10(11):11910-11917.
[8].中国研究型医院学会危重医学专业委员会 , 中国医药教育协会重症医学专业委员会.中国研究型医院,2022,09(1):9-13.
*此文仅用于向医学人士提供科学信息 , 不代表本平台观点